Jubilant Clinsys history

JLSL had acquired the Active Pharmaceutical Ingredients (API) business in the period of 2002.

Jubilant's state-of-the-art Drug Discovery facility was inaugurated in Bangalore during November of the year 2006 the largest of its kind in India for providing integrated Drug Discovery solutions.

JLSL had completed the transaction effective May of the year 2008 to acquire Canada based Draxis Speciality Pharmaceuticals Inc. (Draxis) for US$ 253 million and also in the same month of the same year the company had acquired Speciality Molecules Pvt.

The collaboration in chemistry support has been in existence since 2009 as part of a joint effort with the Lilly TB Drug Discovery Initiative (LTI) and so far has generated hundreds of Novel Chemical Entities (NCEs) - some of which have now been identified for further exploration.

Jubilant's state-of-the-art Drug Discovery facility was inaugurated in Bangalore during November of the year 2006 the largest of its kind in India for providing integrated Drug Discovery solutions. It is also setting up a manufacturing plant at SEZ for Symtet a crop science ingredient for one of the world's largest and safest low cost insecticide through an environment friently process.During the year 2013-14 the company sold its Hospital business to Narayana Health.